MicroRNAs: Turning the Tide in Testicular Cancer.

MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.

European urology. 2019 Jun 21 [Epub]

Nirmish Singla, John T Lafin, Aditya Bagrodia

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: .